December 11, 2017

Cutting Edge Science Meeting Series to End the Opioid Crisis

Meeting Agenda — Using Science to Inform Practice and Policy: A Coordinated Approach to Research Priority Setting

Meeting Agenda

8:30 a.m.
Welcome and Self-Introductions
Nora D. Volkow, M.D., Director, National Institute on Drug Abuse (NIDA)

8:40 a.m.
Introductory Remarks
Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health (NIH)
Eric Hargan, J.D., Acting Secretary, U.S. Department of Health and Human Services
Richard J. Baum, Acting Director, Office of National Drug Control Policy

8:55 a.m.
Meeting Goals and Objectives
Carlos Blanco, M.D., Ph.D., Division Director, NIDA
Jeffrey Lerner, Ph.D., President and Chief Executive Officer, ECRI Institute

9:05 a.m.
The Opioid Crisis: Research-Based Solutions
Nora D. Volkow, M.D., Director, NIDA

9:20 a.m.
Panel 1: Comparative Effectiveness/Implementation of Medication-Assisted Treatment (MAT) for Opioid Use Disorders (OUDs)
Moderator: Lawrence A. Tabak, D.D.S., Ph.D., NIH 

Differential Outcomes of Treatments for OUD by Patient Population, Patient Preference, Treatment Modality, and Treatment Setting
Ryan Mutter, Ph.D., Substance Abuse and Mental Health Services Administration (SAMHSA)

Comparative Effectiveness of Different Treatments for OUD
Kate Berry, M.P.P., America’s Health Insurance Plans

MAT in Primary Care Settings and the Use of Telehealth for Opioid Addiction Treatment
George Sigounas, Ph.D. M.S., Health Resources and Service Administration (HRSA)

10:35 a.m.

10:45 a.m.
Panel 2: Monitoring Quality of Care and Outcomes/Risk Stratification and Screening
Moderator: Francis S. Collins, M.D., Ph.D.

Improvement of Early Identification of Opioid Addiction
Kate Berry, M.P.P., America’s Health Insurance Plans

Genetic and Behavioral Biomarkers of OUD Risk and Resilience
Rachel Ramoni, D.M.D., Sc.D., U.S. Department of Veterans Affairs (VA)

Effectiveness of Interventions for Individuals with Screen-Detected OUD
David Meyers, M.D., Agency for Healthcare Research and Quality

12:00 p.m.

12:45 p.m.
Panel 3: Overdoses
Moderator: Nora D. Volkow, M.D., NIDA

Prevention of Opioid Overdoses and Accidental Deaths
Rachel Ramoni, D.M.D., Sc.D., VA

Treatment of Overdose with Carfentanil and Other Synthetic Opioids
Janet Woodcock, M.D., Food and Drug Administration

Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Use Disorder Following Opioid Overdose and Naloxone Reversal
Steve Daviss, M.D., SAMHSA

2:00 p.m.

2:15 p.m.
Panel 4: Treatment of Pain
Moderator: Nora D. Volkow, M.D., NIDA

Evidence-Based Strategies for Opioid Prescribing and Pain Management
Robin Ikeda, M.D., M.P.H., Centers for Disease Control and Prevention

Treatment of Pain
Kate Berry, M.P.P., America’s Health Insurance Plans

Chronic Pain Management for Special Populations
George Sigounas, Ph.D., HRSA

3:30 p.m.
Next Steps
Nora Volkow, Carlos Blanco, and Jeffrey Lerner

4:30 p.m.

This page last reviewed on December 8, 2017